January 6, 2022   News/Publications

Bill Athenson, CEO of Third Pole Therapeutics, a privately held company developing critical life-sustaining cardio-pulmonary therapies, discusses eNOfit™ the company’s proprietary, tankless, on-demand, electrically generated inhaled Nitric Oxide (iNO) technology that is a safe, accurate and reliable lightweight, wearable device that makes iNO from electricity and the air we breathe, creating a make it and take therapy free from the hazards of compressed gas storage.